DrugPatentWatch Database Preview
Profile for World Intellectual Property Organization (WIPO) Patent: 2011149349
US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2011149349
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | May 18, 2032 | Abbvie Inc | MAVYRET | glecaprevir; pibrentasvir |
➤ Sign Up | Jun 10, 2030 | Abbvie Inc | MAVYRET | glecaprevir; pibrentasvir |
➤ Sign Up | Apr 13, 2032 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | Apr 13, 2032 | Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |